Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24437
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BILLIET, Charlotte | - |
dc.contributor.author | De Ruysscher, Dirk | - |
dc.date.accessioned | 2017-09-08T09:43:33Z | - |
dc.date.available | 2017-09-08T09:43:33Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | JOURNAL OF THORACIC DISEASE, 9(6), p. E585-E586 | - |
dc.identifier.issn | 2072-1439 | - |
dc.identifier.uri | http://hdl.handle.net/1942/24437 | - |
dc.description.sponsorship | This work is part of the Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk, province of Limburg, Flemish government, Hasselt University, Ziekenhuis Oost-Limburg and Jessa Hospital; Charlotte Billiet is supported by the Limburg Cancer Foundation and Kom op tegen kanker. | - |
dc.language.iso | en | - |
dc.publisher | PIONEER BIOSCIENCE PUBL CO | - |
dc.rights | (c) Journal of Thoracic Disease. All rights reserved | - |
dc.title | A closer look at the safety and effectiveness of modern PORT in stage III-N2non-small cell lung cancer | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | E586 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | E585 | - |
dc.identifier.volume | 9 | - |
local.format.pages | 2 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Billiet, Charlotte; De Ruysscher, Dirk] Univ Leuven, Dept Radiat Oncol, KU Leuven, Leuven, Belgium. [Billiet, Charlotte] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium. [De Ruysscher, Dirk] Maastricht Univ, Dept Radiat Oncol MAASTRO, GROW, Med Ctr, Maastricht, Netherlands. | - |
local.publisher.place | HONG KONG | - |
local.type.refereed | Refereed | - |
local.type.specified | Letter | - |
local.class | dsPublValOverrule/author_version_not_expected | - |
dc.identifier.doi | 10.21037/jtd.2017.05.66 | - |
dc.identifier.isi | 000405815000014 | - |
dc.identifier.url | http://jtd.amegroups.com/article/view/13703/11391 | - |
item.contributor | BILLIET, Charlotte | - |
item.contributor | De Ruysscher, Dirk | - |
item.fullcitation | BILLIET, Charlotte & De Ruysscher, Dirk (2017) A closer look at the safety and effectiveness of modern PORT in stage III-N2non-small cell lung cancer. In: JOURNAL OF THORACIC DISEASE, 9(6), p. E585-E586. | - |
item.accessRights | Open Access | - |
item.fulltext | With Fulltext | - |
item.validation | ecoom 2018 | - |
crisitem.journal.issn | 2072-1439 | - |
crisitem.journal.eissn | 2077-6624 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
jtd-09-06-E585.pdf | Published version | 91.05 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.